Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
Reliance Infra, Reliance Power sink up to 19% in 6 sessions amid Rs 17,000 cr loan fraud probe
6/08/2025
Gland Pharma shares rally 6% as brokerages lift ratings, target prices ; here's why
6/08/2025
India needs fiscal push to revive domestic growth : Arvind Sanger
6/08/2025
Reliance Power shares down 31% in 1 month. Should you buy the dip or steer clear ?
6/08/2025
Takyon Networks IPO listing today. Check GMP ahead of debut
6/08/2025
Dollar drifts as investors await Fed governor replacement
6/08/2025
